Description

Standard & Poor's Global Industry Surveys help meet the growing demand for in-depth industry analysis from a European, Asian and Latin American perspective. Designed for strategic planners, management consultants, money managers, researchers, business students, and academic faculty, Global Industry Surveys are an excellent way to get up to speed on current events, future trends and the competitive dynamics of leading industries outside of North America. Intended to complement a subscription to Standard & Poor's flagship industry research product - Industry Surveys - each Global Industry Survey will include the following sections: Current Environment, Industry Trends, How the Industry Operates, Key Industry Ratios and Statistics, Glossary, Industry References and Comparative Company Analysis.

Table of Contents

CURRENT ENVIRONMENT Price cuts hurt in Japan New product highlights Asian governments stress generics Large patent expirations help generics companies Consolidation in Asian generics industry India pushes ahead with pharmaceutical industry reform INDUSTRY PROFILE A flourishing market Japan is world's second-largest drug market Shakeup in China South Korea catches up Australia dominated by affiliates of foreign firms India's increasing global importance Asia's other markets: small, with mixed promise INDUSTRY TRENDS Aging populations ensure long-term demand China is fastest-growing market China and India: friendly competitors Outsourcing to India and China Ongoing price cutting and restructuring in some markets Japan seeks to regain momentum HOW THE INDUSTRY OPERATES Drug industry basics: from discovery to commercialization Differences among markets KEY INDUSTRY RATIOS AND STATISTICS GLOSSARY INDUSTRY REFERENCES COMPARATIVE COMPANY ANALYSIS